Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2007
10/17/2007CN100342908C Pharmaceutical form of administration for peptides, method for its production and use
10/17/2007CN100342856C Composition of danazol semisolid skeleton preparation
10/17/2007CN100342846C Compression molded product and production method therefor
10/17/2007CN100342845C Moisture-proof coating method for Chinese medicine granule
10/16/2007US7282590 Drug conjugates
10/16/2007US7282567 Monoclonal antibody hPAM4
10/16/2007US7282562 Invention is based on identification of proteins (including agonist and antagonist antibodies) which either stimulate or inhibit immune response in mammals; immune related diseases can be treated by suppressing or enhancing immune response
10/16/2007US7282480 Aqueous sustained-release formulations of proteins
10/16/2007US7282327 Pyrimidine base containing compound suitable for enzymatic attachment to a nucleic acid, to provide a mechanism of nucleic acid detection
10/16/2007US7282222 Methods and compositions for directing cells to target organs
10/16/2007US7282217 Rapidly disintegrable tablets
10/16/2007US7282216 Prepared by blending hydrophobic biocompatible, biodegradable polymers or copolymers, such as poly(lactide-co-glycolide), and a biocompatible, amphipathic copolymer having a water absorption ratio of 2 or less; sustained release drug delivery
10/16/2007US7282202 Lactoperoxidase; antiinflammatory; thrombocytosis, myeloma, Castleman syndrome, cardiac myxoma, glomerulonephritis, rheumatoid arthritis, sepsis, influenza-virus infectious disease
10/16/2007US7281641 Stackable low depth tray
10/16/2007CA2336654C Plaster which contains steroids, and a method for the production and use thereof
10/16/2007CA2248087C Improved vision through photodynamic therapy of the eye
10/16/2007CA2124126C Monoclonal antibodies and fv specific for cd2 antigen
10/13/2007CA2578561A1 Topical composition and process for solubilizing an acid in an organic compound
10/11/2007WO2007115180A1 Fullerene assisted cell penetrating peptides
10/11/2007WO2007114549A1 Thermosensitive polyphosphazene-bioactive molecule conjugates, preparation method therof and use thereof
10/11/2007WO2007114380A1 Agent for external application to the skin
10/11/2007WO2007114376A1 Solid pharmaceutical preparation
10/11/2007WO2007114301A1 Stabilizer for composition containing water-soluble polymer thickener
10/11/2007WO2007114300A1 Preservative agent
10/11/2007WO2007114262A1 Casein nanoparticle
10/11/2007WO2007114128A1 Method for production of capsinoid-containing beverage/food
10/11/2007WO2007114013A1 Composition containing lignan compound
10/11/2007WO2007113885A2 Solid oral compositions based on s-adenosyl methionine and/or nadh and process for obtaining them
10/11/2007WO2007113687A2 Camptothecin-cell penetrating peptide conjugates and pharmaceutical compositions containing the same
10/11/2007WO2007113665A2 Polymerized solid lipid nanoparticles for oral or mucosal delivery of therapeutic proteins and peptides
10/11/2007WO2007113572A1 Targeted therapy
10/11/2007WO2007113536A1 A tablet of paracetamol containing an encapsulated flavorant
10/11/2007WO2007113531A2 Topical drug delivery
10/11/2007WO2007113386A1 Peptide conjugates
10/11/2007WO2007113385A1 Diagnostic and therapeutic agents
10/11/2007WO2007113304A1 Novel o-carboxy anhydrides (ocas) comprising a salifiable function and polymers obtained from these ocas
10/11/2007WO2007113224A2 Conjugation process for pnag and a carrier protein
10/11/2007WO2007113223A2 Immunogenic composition
10/11/2007WO2007112794A1 New activated poly(ethylene glycols) and related polymers and their applications
10/11/2007WO2007112581A1 Controlled release delivery device comprising an organosol coat
10/11/2007WO2007112574A1 Extended release composition of venlafaxine
10/11/2007WO2007112567A1 Synthetic archaeal glycolipid adjuvants
10/11/2007WO2007098128A3 Phenylephrine-containing liquid formulations
10/11/2007WO2007085760A3 Anti-infective solution comprising a compound of pyrido(3,2,1-ij)-benzoxadiazine type
10/11/2007WO2007085470A3 Cd19-specific immunotoxin and treatment method
10/11/2007WO2007051830A3 Composition for the transdermal administration of physiologically active agents
10/11/2007WO2007047948A3 Intranasal administration of rapid acting insulin
10/11/2007WO2006087242A3 Intracellular inhibitor peptides and transgenic animals expressing same
10/11/2007US20070238759 Novel Polymorph V of Torasemide
10/11/2007US20070238686 Inhibition of Chronic Myelogenous Leukemic Cell Growth By Liposomal-Antisense Oligodeoxy-Nucleotides Targeting To Grb2 or Crk1
10/11/2007US20070238182 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
10/11/2007US20070238178 Cancer vaccines; infections from Retrovirus, Herpesvirus, Hepadenovirus, Poxvirus, Parvovirus, Papillomavirus, or Papovavirus; reduced side effects; a hairpin RNA having a double stranded region of between 11 to 30 nucleotides; gene expression inhibition
10/11/2007US20070237871 Method for Producing Orally Administrable Edible Agent of Aggregated Substance-Containing Laminate Film Form and Orally Administrable Edible Agent of Aggregated Substance-Containing Laminate Film Form
10/11/2007US20070237836 Strontium compound for treatment of sub-dermal soft tissue pain
10/11/2007US20070237833 Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
10/11/2007US20070237832 Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
10/11/2007US20070237825 Reusable, nonbioadhesive, microporous hydrogel for hydrating and dehydrating dermatological surfaces prepared from hydroxyalkyl (meth)acrylate, a crosslinking agent, water, aliphatic alcohol (isopropanol), and a fibrous filler
10/11/2007US20070237824 Sustained-Release Preparations Of Quinolone Antibiotics
10/11/2007US20070237795 Cryopreservation of Haptenized Tumor Cells
10/11/2007US20070237788 Non-live trivalent influenza vaccine for one-dose intradermal delivery
10/11/2007US20070237785 Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use thereof
10/11/2007CA2658015A1 Camptothecin-peptide conjugates and pharmaceutical compositions containing the same
10/11/2007CA2650498A1 Orally disintegrating tablets
10/11/2007CA2648280A1 Controlled release delivery device comprising an organosol coat
10/11/2007CA2648044A1 Novel o-carboxy anhydrides (ocas) comprising a salifiable function and polymers obtained from these ocas
10/11/2007CA2647982A1 Solid pharmaceutical preparation containing tramadol
10/11/2007CA2647702A1 A tablet of paracetamol containing an encapsulated flavorant
10/11/2007CA2647549A1 Bulking of soft tissue
10/11/2007CA2647455A1 Processes for the conjugation of poly n-acetylated glucosamine to a carrier protein
10/11/2007CA2647450A1 Process for producing a staphylococcal conjugate
10/11/2007CA2647060A1 Synthetic archaeal glycolipid adjuvants
10/11/2007CA2645767A1 Solid oral compositions based on s-adenosyl methionine and/or nadh and process for obtaining them
10/10/2007EP1842857A1 Mutant interferon proteins and use thereof
10/10/2007EP1842585A1 Method for producing fine particle surface-modified with water-soluble substance
10/10/2007EP1842558A1 Composition for inhibiting expression of target gene
10/10/2007EP1842540A1 Sesamin/episesamin compositions
10/10/2007EP1842532A2 Oral sparingly water-soluble antifungal formulations and methods of making the same
10/10/2007EP1842531A1 Composition containing capsicum natural extracts
10/10/2007EP1842431A1 Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses
10/10/2007EP1841796A2 Bispecific domain antibodies targeting serum albumin and glp-1 or pyy
10/10/2007EP1841792A2 Method for producing albumin conjugates containing gyrase inhibitors
10/10/2007EP1841468A2 Laser activated nanothermolysis of cells
10/10/2007EP1841413A2 Direct compression formulation and process
10/10/2007EP1758591B1 Invert emulsion composition containing calcitriol and clobetasol 17-propionate, and uses thereof in cosmetics and dermatology
10/10/2007EP1697050B1 Fiber rich fraction of trigonella foenum-graceumseeds and its use as a pharmaceutical excipient
10/10/2007EP1624897B1 Hiv prodrugs cleavable by cd26
10/10/2007EP1471894B1 Cyclodextrines for use as suspension stabilizers in pressure-liquefied propellants
10/10/2007EP1404295B1 Sustained release drug delivery devices with coated drug cores
10/10/2007EP1401504B1 Uv-screening peptide-flavonoid conjugates
10/10/2007EP1399153B1 Pharmaceutical composition comprising orlistat and a fatty acid or salt thereof
10/10/2007EP1372608B1 Medical aerosol formulations
10/10/2007EP1343478B1 Induced phase transition method for the production of microparticles containing hydrophilic active agents
10/10/2007EP1265683B1 Methods for extraction and reaction using supercritical fluids
10/10/2007EP1240396B1 A ventilating device for ventilating through a ridge
10/10/2007EP1162950B1 Media in the form of complex dispersions, method for preparing same and uses
10/10/2007EP1068241B1 Antibody variants and fragments thereof
10/10/2007EP0957939B1 Use of an emulsifier system for increasing penetration flux of pharmaceutical agents
10/10/2007CN101052650A Novel peptide for treating obesity
10/10/2007CN101052649A Peptide for treating obesity
10/10/2007CN101052647A Novel peptide for treating obesity
1 ... 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 ... 1712